Skip to content

This site uses cookies to give you a better experience. By clicking “Accept,” you consent that you agree to our Privacy Policy.

Accept

This site is intended for US audiences only.

MENU
INREBIC® (fedratinib) is a prescription medicine used to treat adults with certain types of myelofibrosis (MF). It is not known if INREBIC is safe and effective in children.

Resources and support

HCP and Patient Discussing Patient Resources

On this page:

    BMS Access Support® can provide patient access and reimbursement assistance

    Bristol Myers Squibb™ Access Support® Site

     

    BMS Access Support® Can Provide
    Patient Access and Reimbursement Assistance

    Bristol Myers Squibb is committed to helping patients gain access to their prescribed BMS medications. That’s why we offer BMS Access Support. BMS Access Support provides resources to help patients understand their insurance coverage. In addition, we can share information on sources of financial support, including co-pay assistance for eligible commercially insured patients.

     

    BMS Support Center Icon

    How BMS Access Support May Help
    Find out how BMS can work with patients and their healthcare providers to help access a prescribed BMS medication.

    Financial Support Icon

    Financial Support Options
    There may be programs and services that could help with the cost of treatment. Learn about what options are available.

    Videos and Reimbursement Resources Icons

    Additional Resources
    We provide videos, tools, and other resources that may help with your access and reimbursement needs.

     

    Have Questions About Our Program or Possible Financial Support?

    If you have questions about coverage for a prescribed BMS medication, BMS Access Support may be able to help. Patients and their healthcare providers can complete an enrollment form to learn about programs that may be of assistance. Visit our website or contact BMS Access Support to learn more.

     

    Mobile Phone Icon

    Call Bristol Myers Squibb Access Support at 1-800-861-0048, 8 AM to 8 PM ET, Monday-Friday

    Desktop Icon

    Visit www.BMSAccessSupport.com

     

    The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and the patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

     

    Talking about MF with your doctor begins with some crucial questions

    It’s important to be upfront about what you’re experiencing. Honest communication with your care team can help you make informative choices about your health. It also helps to build a strong partnership. A strong team can mean more support for you.

    Try using these questions to get the information you need. Consider taking notes as you hear the answers to refer to after your appointment.

    Talk about your symptoms.

    • I’m on treatment, but I’m still feeling tired, have pain, etc.
    • I have symptoms such as nausea, diarrhea, itchiness, etc. Is there anything you can suggest to help manage them?
    • Be as specific and open as you can with your HCP by asking questions and communicating specific information about the symptoms you might be experiencing
    • Should I expect to feel better or is this just how it’s going to be?

    Ask about your options.

    • What are my treatment options?
    • What do you consider when determining the appropriate treatment
      for me?

    Ask about INREBIC.

    • What are the side effects with INREBIC that I should be aware of?
    • Are there any side effects that I experience which signal I call you
      immediately?
    • Does INREBIC interact with any other medications I’m currently
      taking?
    • What can I expect when taking INREBIC?

    Ask other important questions about INREBIC.

    • Will my health insurance pay for INREBIC?
    • What if my INREBIC prescription is denied by my health insurance?
    • Does INREBIC have a patient support program?
    • How do I get my INREBIC prescription through a specialty pharmacy?

    Ask loved ones for help.

    • Would you come with me to my appointments?
    • Can you help me prepare for my appointments?
    • Can you take notes while I listen to what the doctor says?
    • Will you help me remember to take my medication?
    • Can you help me track or remind me to track my symptoms?
    • Can you help me discuss or remind me to discuss my questions
      with my doctor?

    MF Organizations and Advocacy Groups

    This list of independent organizations is provided as a resource for obtaining support and information related to MF.

    This list does not indicate endorsement by Bristol Myers Squibb of an organization or its communications.

    MPN Research Foundation Logompnresearchfoundation.org

    Patient Power Logopatientpower.info

    MPN Advocacy & Education International Logompnadvocacy.com

    Cancer Support Community Logocancersupportcommunity.org

    Get Patient Brochure

    Knowledge is power. Download a patient brochure about INREBIC to refer to if you have any questions.

    Download

    INREBIC® Patient Support Brochure

    Reaching out to others

    Living with myelofibrosis may be particularly stressful for patients. They might not know how to talk about it, and it may be hard to know exactly what kind of emotional support they need.

     

    • Be realistic about what you can do, and learn how to pass on the responsibilities to others if necessary
    • Tell people how they can help, as they may not be aware of what caregiving involves
    • Work with friends and family to make a plan of what needs to get done
    • Let go of tasks that can wait until later because you can always go back to them at another time

    Sign up for more information and resources.

    Register Now

    Indication

    What is INREBIC® (fedratinib)?

    INREBIC is a prescription medicine used to treat adults with certain types of myelofibrosis (MF). It is not known if INREBIC is safe and effective in children.


    Important Safety Information

     

    WARNING: ENCEPHALOPATHY INCLUDING WERNICKE’S

    What is the most important information I should know about INREBIC?

    INREBIC may cause serious side effects, including:

    • Encephalopathy (including Wernicke’s encephalopathy). A serious and sometimes fatal neurological problem called encephalopathy (including Wernicke’s encephalopathy) has happened in some people who take INREBIC. Wernicke’s encephalopathy is a neurologic emergency that can happen if you do not have enough vitamin B1 (thiamine) in your body. Your healthcare provider will do a blood test to check your vitamin B1 level before starting and during treatment with INREBIC. Your healthcare provider may tell you to stop taking INREBIC and take a vitamin B1 supplement if you develop side effects during treatment with INREBIC.

     

    Call your healthcare provider right away if you develop diarrhea, nausea, or vomiting that does not respond to treatment.

    Get emergency medical help right away if you develop the following:

      • confusion, memory problems, or drowsiness
      • problems with balance and movement, such as difficulty walking
      • eye problems, such as double or blurred vision or abnormal eye movements

     

    Call your healthcare provider if you experience rapid weight loss or weight loss that does not get better with treatment.

     

    Before taking INREBIC, tell your healthcare provider about all your medical conditions, including if you:

    • have low red blood cell or platelet counts
    • have or have had liver problems
    • have or have had kidney problems
    • have had cancer in the past
    • are a current or past smoker
    • have had a blood clot, heart attack, other heart problems, or stroke
    • are breastfeeding or plan to breastfeed. It is not known if INREBIC passes into your breast milk. You should not breastfeed during treatment with INREBIC and for at least 1 month after your last dose. Talk to your healthcare provider about the best way to feed your baby during treatment with INREBIC.

     

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

     

    INREBIC and other medicines may affect each other causing unwanted side effects. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

     

    How should I take INREBIC?

     

    What are the possible side effects of INREBIC?
    INREBIC can cause serious side effects, including:

     

    The most common side effects of INREBIC include:

     

    These are not all of the possible side effects of INREBIC.

     

    Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

     

    Please see full Prescribing Information for INREBIC including BOXED WARNING and Medication Guide.

    You are now leaving
    INREBIC.com.

    Click “OK” to proceed or “Cancel” to remain on INREBIC.com

    OK

    Please select who you are

    I am a patient or caregiver